Compare disease-modifying therapies (DMTs) for multiple sclerosis. Options range from platform therapies to high-efficacy B-cell depleting agents. Choice depends on disease activity, safety profile, route preference, and insurance coverage.
Select any two to compare side by side
Denied one of these medications?
Ellen can decode your denial letter, identify why you were denied, and generate a personalized appeal — free.